tirzepatide adverse effects Side What are the common gastrointestinal
Description
This dual action makes tirzepatide a promising option for people looking to improve their blood sugar control and potentially lose weight
Tirzepatides CV outcomes trial (SURPASS-CVOT) is ongoing as of 2026
Plan for long-term treatment or have a comprehensive maintenance strategy in place before stopping
Medicaid: Mounjaro coverage varies by state
Youre only permitted a very small amount of daily carbohydrate, one of the three primary macronutrients (alongside protein and fat)
Rotating injection sites can help avoid issues such as: Scar tissue build-up Irritation Bruising Swelling Pain Your provider should walk you through self-administering injections before you begin the treatment
